<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR12">
 <label>12.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Van Esser</surname>
    <given-names>JW</given-names>
   </name>
   <name>
    <surname>Niesters</surname>
    <given-names>HG</given-names>
   </name>
   <name>
    <surname>van der Holt</surname>
    <given-names>B</given-names>
   </name>
   <name>
    <surname>Meijer</surname>
    <given-names>E</given-names>
   </name>
   <name>
    <surname>Osterhaus</surname>
    <given-names>AD</given-names>
   </name>
   <name>
    <surname>Gratama</surname>
    <given-names>JW</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Prevention of Epsteinâˆ’Barr virus-lymphoproliferative disease by molecular monitoring and preemptive rituximab in high-risk patients after allogeneic stem cell transplantation</article-title>
  <source>Blood</source>
  <year>2002</year>
  <volume>99</volume>
  <fpage>4364</fpage>
  <lpage>9</lpage>
  <pub-id pub-id-type="doi">10.1182/blood.V99.12.4364</pub-id>
  <pub-id pub-id-type="pmid">12036863</pub-id>
 </element-citation>
</ref>
